These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 36092715)
1. Role of Aβ in Alzheimer's-related synaptic dysfunction. Zhang H; Jiang X; Ma L; Wei W; Li Z; Chang S; Wen J; Sun J; Li H Front Cell Dev Biol; 2022; 10():964075. PubMed ID: 36092715 [TBL] [Abstract][Full Text] [Related]
6. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Tu S; Okamoto S; Lipton SA; Xu H Mol Neurodegener; 2014 Nov; 9():48. PubMed ID: 25394486 [TBL] [Abstract][Full Text] [Related]
7. Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future. Srivastava A; Das B; Yao AY; Yan R J Alzheimers Dis; 2020; 78(4):1345-1361. PubMed ID: 33325389 [TBL] [Abstract][Full Text] [Related]
8. The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease. Rudy CC; Hunsberger HC; Weitzner DS; Reed MN Aging Dis; 2015 Mar; 6(2):131-48. PubMed ID: 25821641 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164 [TBL] [Abstract][Full Text] [Related]
10. Synaptic changes in Alzheimer's disease and its models. Pozueta J; Lefort R; Shelanski ML Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952 [TBL] [Abstract][Full Text] [Related]
11. Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities. Li S; Stern AM Mol Psychiatry; 2022 Aug; 27(8):3182-3191. PubMed ID: 35484241 [TBL] [Abstract][Full Text] [Related]
12. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Li S; Hong S; Shepardson NE; Walsh DM; Shankar GM; Selkoe D Neuron; 2009 Jun; 62(6):788-801. PubMed ID: 19555648 [TBL] [Abstract][Full Text] [Related]
13. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051 [TBL] [Abstract][Full Text] [Related]
14. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases. Wu M; Zhang M; Yin X; Chen K; Hu Z; Zhou Q; Cao X; Chen Z; Liu D Transl Neurodegener; 2021 Nov; 10(1):45. PubMed ID: 34753506 [TBL] [Abstract][Full Text] [Related]
15. β-Amyloid disruption of LTP/LTD balance is mediated by AKAP150-anchored PKA and Calcineurin regulation of Ca Sanderson JL; Freund RK; Gorski JA; Dell'Acqua ML Cell Rep; 2021 Oct; 37(1):109786. PubMed ID: 34610314 [TBL] [Abstract][Full Text] [Related]
16. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172 [TBL] [Abstract][Full Text] [Related]
17. A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain. Li S; Selkoe DJ J Neurochem; 2020 Sep; 154(6):583-597. PubMed ID: 32180217 [TBL] [Abstract][Full Text] [Related]
18. Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer's Disease. Perdigão C; Barata MA; Araújo MN; Mirfakhar FS; Castanheira J; Guimas Almeida C Front Cell Neurosci; 2020; 14():72. PubMed ID: 32362813 [TBL] [Abstract][Full Text] [Related]
19. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease. Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400 [TBL] [Abstract][Full Text] [Related]
20. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP. Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]